{"@context":{"@vocab":"https://schema.org/"},"@type":"Drug","@id":"https://api.morvs.ai/drug-product/0006-3856#drug","name":"RECARBRIO","alternateName":"imipenem anhydrous, cilastatin, and relebactam anhydrous","identifier":[{"@type":"PropertyValue","propertyID":"FDA National Drug Code (NDC)","value":"0006-3856"},{"@type":"PropertyValue","propertyID":"FDA application number","value":"NDA212819"},{"@type":"PropertyValue","propertyID":"UNII","value":"141A6AMN38|Q20IM7HE75|1OQF7TT3PF"},{"@type":"PropertyValue","propertyID":"SPL Set ID","value":"be32f468-738b-40df-a425-591e12f65159"}],"activeIngredient":"CILASTATIN, IMIPENEM ANHYDROUS, RELEBACTAM ANHYDROUS","administrationRoute":["INTRAVENOUS"],"dosageForm":"INJECTION, POWDER, FOR SOLUTION","manufacturer":{"@type":"Organization","name":"Merck Sharp & Dohme LLC"},"drugClass":[],"isAvailableGenerically":false,"legalStatus":"HUMAN PRESCRIPTION DRUG","sameAs":["https://api.morvs.ai/drug-approval/NDA212819","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=be32f468-738b-40df-a425-591e12f65159","https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0006-3856"],"isAccessibleForFree":true,"license":"https://creativecommons.org/publicdomain/zero/1.0/","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://creativecommons.org/publicdomain/zero/1.0/","primary_source":"https://open.fda.gov/apis/drug/ndc/","generated_at":"2026-11-03T10:56:21.077Z"}}